Membranous Nephropathy Clinical Trials

Find Membranous Nephropathy Clinical Trials Near You

Implementing Precision Medicine for Glomerular Diseases in the Nephrotic Syndrome Study Network (NEPTUNE)

Status: Recruiting
Location: See all (16) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 80
Healthy Volunteers: f
View:

• Consented and eligible participants in the biopsied or non-biopsied cohorts of the NEPTUNE observational study

• Must be potentially eligible for the NEPTUNE Match partnering trials (e.g. if no trial is enrolling a participant under age 6, those under 6 are not eligible).

• Note: NEPTUNE Match partnering trials and associated eligibility criteria are expected to be dynamic and change as trial protocols are developed, activated, and amended.

• Regular nephrology healthcare provided at a NEPTUNE study site.

• Willing and able to consent, and as appropriate assent, to participate in NEPTUNE Match

Locations
United States
Georgia
Emory University Hospital - Children's Hospital of Atlanta
RECRUITING
Atlanta
Illinois
John H. Stroger, Jr., Hospital of Cook County
RECRUITING
Chicago
Kansas
University of Kansas Medical Center
RECRUITING
Kansas City
Maryland
Johns Hopkins Medicine
RECRUITING
Baltimore
Michigan
University of Michigan
ENROLLING_BY_INVITATION
Ann Arbor
Missouri
Children's Mercy Hospital
RECRUITING
Kansas City
North Carolina
University of North Carolina Chapel Hill
RECRUITING
Chapel Hill
New York
Northwell/Cohen's Children's Hospital
RECRUITING
New Hyde Park
Columbia University Medical Center
RECRUITING
New York
Ohio
Cleveland Clinic Foundation
RECRUITING
Cleveland
Pennsylvania
Hospital of the University of Pennsylvania
RECRUITING
Philadelphia
Temple University
RECRUITING
Philadelphia
South Carolina
Medical University of South Carolina
RECRUITING
Charlotte
Washington
Seattle Children's Hospital
RECRUITING
Seattle
University of Washington Medical Center
RECRUITING
Seattle
Providence Sacred Heart Medical Center
RECRUITING
Spokane
Contact Information
Primary
Hailey E Desmond, MS
heturner@med.umich.edu
734-232-4851
Backup
Chrysta C Lienczewski, BS
boridley@med.umich.edu
734-615-5021
Time Frame
Start Date: 2022-05-02
Estimated Completion Date: 2029-06-30
Participants
Target number of participants: 375
Treatments
Other: NEPTUNE Match Participants
Approximately 375 participants will be consented from the NEPTUNE observational study with age and demographic groups representing the patient population in the NEPTUNE study site geographical areas.~NEPTUNE observational cohort eligibility includes: participants in NEPTUNE observational cohort A are of any age and have a biopsy-confirmed diagnosis of Focal Segmental Glomerulosclerosis (FSGS), Minimal Change Disease (MCD), or Membranous Nephropathy (MN). Participants in NEPTUNE observational cohort B have documented NS based on proteinuria, serum albumin, and/or edema with age of onset less than 19 years.
Authors
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: University of Michigan

This content was sourced from clinicaltrials.gov

Similar Clinical Trials